openPR Logo
Press release

Live Attenuated Polio Vaccine Market Size Projected To Reach 2.71 Billion By 2034 With A Cagr Of 7.9%

06-11-2025 09:58 AM CET | Health & Medicine

Press release from: The Business Research Company

Live Attenuated Polio Vaccine

Live Attenuated Polio Vaccine

Our market reports now include the latest updates on global tariffs, trade impacts, and evolving supply chain dynamics.

What Is the Projected Growth of the Live Attenuated Polio Vaccine Market?
In recent years, there has been a significant increase in the size of the live attenuated polio vaccine market. Its growth is projected to rise from $1.85 billion in 2024 to $2.00 billion in 2025, with a compound annual growth rate (CAGR) of 8.3%. Factors that led to this growth in the historic period include mass vaccination campaigns, the surfacing of vaccine-derived poliovirus worries, government-led immunization initiatives, increased public consciousness and knowledge, and the availability and affordability of vaccines.

Expectations are high for a significant expansion of the live attenuated polio vaccine market size in the coming years, with predictions placing its value at $2.71 billion in 2029, growing at a compound annual growth rate (CAGR) of 7.9%. The predicted growth for the forecast period can be credited to developments in vaccine stability and longevity, re-emergence of polio instances in disputed regions, dwindling donor interest in eradication initiatives, the broadening of standard immunization programs, and escalating research and development for safer strains of the live attenuated vaccine. Key trends projected for the forecast period include the rise of vaccine-derived poliovirus, the evolution of the oral polio vaccine, advancements in vaccine formulation technology, the integration of digital technology, and collaborations between public and private sectors.

Purchase the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/customise?id=24280&type=smp

What Are the Different Live Attenuated Polio Vaccine Market Segments?
The live attenuated polio vaccine market covered in this report is segmented -

1) By Vaccine Type: Monovalent, Bivalent, Trivalent
2) By Administration Route: Oral Administration, Intramuscular Injection, Subcutaneous Injection
3) By Age Group: Infants (0-1 years), Children (1-5 years), Adults (Above 5 years)
4) By End-User: Hospitals, Clinics, Public Health Agencies, Other End-Users

Subsegments:
1) Monovalent: mOPV1 For Serotype 1
2) Bivalent: Type 1, Type 3
3) Trivalent: Poliovirus Type 1, Poliovirus Type 2, Poliovirus Type 3

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=24280&type=smp

What Are the Primary Drivers Shaping the Live Attenuated Polio Vaccine Market?
The burgeoning of vaccination initiatives is anticipated to stimulate the progress of the live attenuated polio vaccine market. These initiatives, planned by governmental bodies, health organizations, and similar institutions, aim to distribute vaccines to populations for preventing the transmission of contagious diseases. The growth of immunization programs is chiefly attributed to the heightened global realization of the need for disease prevention and robust backing from governments, international health bodies, and funding agencies. The programs bolster the live attenuated polio vaccine (LAPV) by assuring extensive dispersion, secure management, and comprehensive coverage, all contributing to herd immunity, preventing virus transmission, and facilitating worldwide polio eradication. For instance, the Centers for Disease Control and Prevention, a national public health institution based in the US, reported in October 2023, that the global coverage for the first dose of the diphtheria-tetanus-pertussis (DTP) vaccine had an uptick from 86% to 89% between 2021 and 2022. Thus, the magnification of immunization programs is fuelling the growth of the live attenuated polio vaccine market.

Which Companies Are Leading in the Live Attenuated Polio Vaccine Market?
Major companies operating in the live attenuated polio vaccine market are Sanofi Pasteur, GlaxoSmithKline plc, LG Chem Ltd., Serum Institute of India Pvt. Ltd., Biological E. Limited, Indian Immunologicals Limited, Sinovac Biotech Ltd., Shenzhen Kangtai Biological Products Co. Ltd., Vabiotech, Emergent BioSolutions Inc., Valneva SE, Bio Farma, PT Bio Farm, Bilthoven Bio, Panacea Biotec, Haffkine Biopharmaceutical, Panacea Biotec Ltd., Zydus Cadila, Liaoning Cheng Da Biotechnology Co.Ltd, Bharat Biotech International Limited

What Live Attenuated Polio Vaccine Market Trends Are Gaining Traction Across Different Segments?
Companies that play a significant role in the live attenuated polio vaccine market are striving to obtain regulatory permissions, thereby ensuring their vaccines adhere to global health guidelines in terms of safety and effectiveness. Such permissions are essentially formal approvals by governmental health authorities or regulatory entities which sanction a product's marketing, selling, and usage in a specific region or country. For instance, in July 2024, Biological E, a firm based in India that specializes in pharmaceuticals and biologics, was accredited by the World Health Organization (WHO) for its innovative oral polio vaccine type 2 (nOPV2). This updated live oral vaccine, which is more advanced than traditional oral polio vaccines, is aimed at tackling circulating vaccine-derived poliovirus type 2 (cVDPV2) outbreaks more effectively. The nOPV2 is strategically developed with superior genetic stability to minimize the chance of the vaccine virus returning to a virulent form, which posed a risk with previous vaccines.

Get the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/report/live-attenuated-polio-vaccine-global-market-report

What Are the Top Revenue-Generating Geographies in the Live Attenuated Polio Vaccine Market?
North America was the largest region in the live attenuated polio vaccine market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the live attenuated polio vaccine market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Frequently Asked Questions:
1. What Is the Market Size and Growth Rate of the Live Attenuated Polio Vaccine Market?
2. What is the CAGR expected in the Live Attenuated Polio Vaccine Market?
3. What Are the Key Innovations Transforming the Live Attenuated Polio Vaccine Industry?
4. Which Region Is Leading the Live Attenuated Polio Vaccine Market?

Why This Report Matters:

Competitive overview: This report analyzes the competitive landscape of the 3D imaging software market, evaluating key players on market share, revenue, and growth factors.

Informed Decisions: Understand key strategies related to products, segmentation, and industry trends.

Efficient Research: Quickly identify market growth, leading players, and major segments.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Live Attenuated Polio Vaccine Market Size Projected To Reach 2.71 Billion By 2034 With A Cagr Of 7.9% here

News-ID: 4061236 • Views:

More Releases from The Business Research Company

Seed Treatment Fungicides Market to Grow at 9.3% CAGR, Reaching $3.15 Billion by 2029
Seed Treatment Fungicides Market to Grow at 9.3% CAGR, Reaching $3.15 Billion by …
Use ONLINE30 for 30% savings on global market reports and stay on top of tariff updates, market trends, and economic shifts worldwide. Seed Treatment Fungicides Market Outlook: How is the Market Expected to Grow by 2025? Over the past few years, the market for seed treatment fungicides has seen robust growth. Its market value is projected to rise from $2.07 billion in 2024 to $2.21 billion in 2025, signifying a compound annual
Rheology Modifiers Market Growth to be Driven by Emerging Trends | $10.92 Billion by 2029
Rheology Modifiers Market Growth to be Driven by Emerging Trends | $10.92 Billio …
Stay informed on tariff shifts, macro trends, and global economic changes-use code ONLINE30 to enjoy 30% off our global market reports. What is the Projected Market Size of the Rheology Modifiers Industry? There has been a consistent expansion in the size of the rheology modifiers market in the past few years. The market, which was worth $8.59 billion in 2024, is projected to increase to $8.89 billion in 2025, demonstrating a compound
Polyurethane Foam Market to Record 8.4% CAGR Growth Through 2029 | Global Analysis Report
Polyurethane Foam Market to Record 8.4% CAGR Growth Through 2029 | Global Analys …
Use ONLINE30 for 30% savings on global market reports and stay on top of tariff updates, market trends, and economic shifts worldwide. Polyurethane Foam Market Outlook: How is the Market Expected to Grow by 2025? In recent years, the size of the polyurethane foam market has experienced substantial growth. It is projected to increase from a value of $54.27 billion in 2024 to $57.26 billion in 2025, indicating a compound annual growth
Pharmaceutical Intermediates Market Size to Reach $46.04 Billion by 2029 | Growth at 7.1% CAGR Forecast
Pharmaceutical Intermediates Market Size to Reach $46.04 Billion by 2029 | Growt …
Stay informed on tariff shifts, macro trends, and global economic changes-use code ONLINE30 to enjoy 30% off our global market reports. What is the Projected Market Size of the Pharmaceutical Intermediates Industry? There has been consistent growth in the market size of pharmaceutical intermediates over the past few years. The market is predicted to increase from a value of $33.37 billion in 2024, up to $34.95 billion in 2025, with a compound

All 5 Releases


More Releases for Polio

Polio Vaccine Market Therapeutic Survey Reviews, Analysis 2020
The report titled "Polio Vaccine Market" report will be very useful to get a stronger and effective business outlook. It provides an in-depth analysis of different attributes of industries such as trends, SWOT analysis, policies, and clients operating in several regions. The qualitative and quantitative analysis techniques have been used by analysts to provide accurate and applicable data to the readers, business owners and industry experts. The global Polio Vaccine market
Polio Vaccines Market Opportunity Analysis, 2018-2026
Poliomyelitis is highly infectious disease caused by poliovirus. It is also known as polio or infantile paralysis. The virus belongs to genus Enterovirus which is a type of single-stranded RNA virus. There are three serotypes of poliovirus: P1, P2 and P3 and development of immunity to one serotype does not produce significant immunity to the other serotypes. The virus is transmitted primarily via the fecal-oral route, by ingesting contaminated food
2017 Report: Global Polio Vaccine Market Competition by Manufacturers
This report studies Polio Vaccine in Global market, especially in North America, Europe, China, Japan, Southeast Asia and India, focuses on top manufacturers in global market, with capacity, production, price, revenue and market share for each manufacturer, covering Astellas Pharma CSL Limited Emergent BioSolutions GlaxoSmithKline Johnson&Johnson MedImmune Merck ... Request a sample of this report @ http://www.reportsweb.com/inquiry&RW0001609399/sample . Market Segment by Regions, this report splits Global into several key Regions, with production, consumption, revenue, market share and growth rate of
Global POLIO VACCINE Market Research Report 2017
Polio Vaccine Report This report studies sales (consumption) of Polio Vaccine in Global market, especially in United States, China, Europe and Japan, focuses on top players in these regions/countries, with sales, price, revenue and market share for each player in these regions, covering Astellas Pharma CSL Limited Emergent BioSolutions GlaxoSmithKline Johnson&Johnson MedImmune Merck Try Sample Report @ https://www.wiseguyreports.com/sample-request/982168-global-polio-vaccine-sales-market-report-2017 Market Segment by Regions, this report splits Global into several key Regions, with sales
Global Polio Vaccine Market Report 2017 | DecisionDatabases.com
The Report added on Polio Vaccine Market added by DecisionDatabases.com to its huge database. This research study is segmented on the basis of applications, technology, geography, and types. The Report provides a detailed Polio Vaccine Industry overview along with the analysis of industry’s gross margin, cost structure, consumption value and sale price. The leading companies of the Polio Vaccine Market, manufacturers, and distributors are profiled in the report along with
World Polio Day 2010: Post Polio Syndrome Is Here To Stay
Bielefeld, 2010/10/22 Every year on October 28 a disease seemingly irrelevant and long forgotten in our part of the world is moving into the public focus: Poliomyelitis or polio; a dangerous, highly contagious viral infection that has claimed victims numbering in the tens of thousands in the not-too-distant past. For a sizeable fraction of these, the infection proved fatal. And the disease rages on. The virus can be eradicated – Post Polio